Skip to main content
. 2020 Mar 24;25(4):932–940. doi: 10.1007/s11605-020-04570-1

Table 2.

30-day postoperative outcomes

No frailty (n = 3245) Low frailty (n = 2913) Intermediate frailty (n = 649) High frailty (n = 91) p value
Mortality, n (%) 6 (0.2) 38 (1.3) 39 (6.0) 18 (20) < 0.001
Clavien IV complications, n (%) 48 (1.5) 156 (5.4) 73 (11) 25 (28) < 0.001
Superficial SSI, n (%) 37 (1.1) 65 (2.2) 18 (2.8) 4.0 (4.4) < 0.001
Deep incisional SSI, n (%) 7.0 (0.2) 12 (0.4) 6.0 (0.9) 4.0 (4.4) < 0.001
Organ space SSI, n (%) 28 (0.9) 45 (1.5) 11 (1.7) 2.0 (2.2) 0.052
Pneumonia, n (%) 11 (0.3) 54 (1.9) 31 (4.8) 6.0 (6.6) < 0.001
Reintubation, n (%) 11 (0.3) 54 (1.9) 31 (4.8) 8.0 (8.8) < 0.001
Pulmonary embolism, n (%) 4.0 (0.1) 11 (0.4) 3 (0.5) 0 (0) 0.162
Deep venous thrombosis, n (%) 5.0 (0.2) 9.0 (0.3) 7.0 (1.1) 1.0 (1.1) 0.001
Ventilator dependence, n (%) 5.0 (0.2) 55 (1.9) 49 (7.6) 16 (18) < 0.001
Progressive renal insufficiency, n (%) 3.0 (0.1) 28 (1.0) 11 (1.7) 9.0 (9.9) <0.001
Acute renal failure, n (%) 3.0 (0.1) 18 (0.6) 10 (1.5) 7.0 (7.7) < 0.001
Urinary tract infection, n (%) 12 (0.4) 42 (1.4) 12 (1.8) 2 (2.2) < 0.001
Stroke, n (%) 0 (0) 6.0 (0.2) 6.0 (0.9) 1.0 (1.1) < 0.001
Cardiac arrest requiring CPR, n (%) 30 (0.1) 8.0 (0.3) 10 (1.5) 7.0 (7.7) < 0.001
Myocardial infarction, n (%) 2.0 (0.1) 13 (0.4) 13 (2.0) 0 (0) < 0.001
Sepsis, n (%) 29 (0.9) 66 (2.3) 23 (3.5) 8.0 (8.8) < 0.001
Septic shock, n (%) 12 (0.4) 39 (1.3) 28 (4.3) 8.0 (8.8) < 0.001
Reoperation, n (%) 37 (1.1) 81 (2.8) 34 (5.2) 8.0 (8.8) < 0.001
Length of stay, days, median (IQR) 2 (1–4) 4 (2–6) 7 (4–11) 13 (7–23) < 0.001
Operative time, minutes, median (IQR) 75 (52–104) 84 (59–115) 84 (63–118) 87 (68–112) < 0.001

No frailty = mFI 0, Low frailty = mFI 1–2, Intermediate frailty = mFI 3–4, High frailty = mFI ≥ 5; SSI, surgical site infection; italic font represents statistically significant associations